INS and type 1 diabetes mellitus: Our understanding of type 1 diabetes (T1D) pathophysiology has advanced significantly in the last 100 years since discovering insulin as a T1D treatment, but additional biomarkers of its earliest stages could help determine its cause and develop more refined and targeted prevention approaches.